Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation

(1) Background: Icariin is the main component of the Chinese herb Epimedium. A number of studies have shown that it alleviates abnormal lipid metabolism. However, it is not clear whether and how icariin can ameliorate hepatic steatosis with polycystic ovary syndrome (PCOS). This study was designed to explore the anti-hepatosteatosis effect of icariin in rats with polycystic ovary syndrome. (2) Methods: Female Sprague Dawley(SD)rats were treated with a high-fat diet and letrozole for 21 days to make nonalcoholic fatty liver disease (NAFLD) in the polycystic ovary syndrome model. Then model rats were treated with icariin (by gavage, once daily) for 28 days. Serum hormones and biochemical variables were determined by ELISA or enzyme. RNA-sequence analysis was used to enrich related target pathways. Then, quantitative Real-time PCR (qRT-PCR) and Western blot were performed to verify target genes and proteins. (3) Results: Icariin treatment reduced excess serum levels of Testosterone (T), Estradiol (E2), Luteinizing hormone (LH), Follicle-stimulating hormone (FSH), LH/FSH ratio, insulin, triglycerides (TG), and aspartate aminotransferase (AST) in high-fat diet (HFD) and letrozole fed rats. Meanwhile, icariin ameliorated HFD and letrozole-induced fatty liver, as evidenced by a reduction in excess triglyceride accumulation, vacuolization, and Oil Red O staining area in the liver of model rats. Results of RNA-sequencing, western blotting, and qRT-PCR analyses indicated that icariin up-regulated fatty acid translocase (CD36), in mitochondria, and peroxisome proliferator-activated receptor α (PPARα) expression, which led to the enhancement of fatty acid oxidation molecules, such as cytochrome P450, family 4, subfamily a, polypeptide 3 (CYP4A3), carnitine palmitoyltransferase 1 α (CPT1α), acyl-CoA oxidase 1 (ACOX1), medium-chain acyl-CoA dehydrogenase (MCAD), and long-chain acyl-CoA dehydrogenase (LCAD). Besides, icariin reduced lipid synthesis, which elicited stearoyl-Coenzyme A desaturase 1 (SCD1), fatty acid synthase (FASN), and acetyl-CoA (ACC). (4) Conclusion: Icariin showed an ameliorative effect on hepatic steatosis induced by HFD and letrozole, which was associated with improved fatty acid oxidation and reduced lipid accumulation in the liver.

[1]  Peter H. Sudmant,et al.  The hepatic integrated stress response suppresses the somatotroph axis to control liver damage in nonalcoholic fatty liver disease , 2022, Cell reports.

[2]  Zhiman Li,et al.  Diosgenin Ameliorated Type II Diabetes-Associated Nonalcoholic Fatty Liver Disease through Inhibiting De Novo Lipogenesis and Improving Fatty Acid Oxidation and Mitochondrial Function in Rats , 2022, Nutrients.

[3]  Myeong Jun Song,et al.  Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin , 2022, Frontiers in Endocrinology.

[4]  S. F. Ibrahim,et al.  Kelulut Honey Ameliorates Oestrus Cycle, Hormonal Profiles, and Oxidative Stress in Letrozole-Induced Polycystic Ovary Syndrome Rats , 2022, Antioxidants.

[5]  E. Fröhlich,et al.  Insight into Potential Interactions of Thyroid Hormones, Sex Hormones and Their Stimulating Hormones in the Development of Non-Alcoholic Fatty Liver Disease , 2022, Metabolites.

[6]  Zhiwei Chen,et al.  Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation , 2022, Frontiers in Pharmacology.

[7]  X. Ruan,et al.  Inhibition of fatty acid translocase (FAT/CD36) palmitoylation enhances hepatic fatty acid β-oxidation by increasing its localization to mitochondria and interaction with long-chain acyl-CoA synthetase 1. , 2022, Antioxidants & redox signaling.

[8]  J. Bila,et al.  Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS) , 2022, Biomedicines.

[9]  Jimmy D Bell,et al.  Genetic Evidence for Different Adiposity Phenotypes and Their Opposing Influences on Ectopic Fat and Risk of Cardiometabolic Disease , 2021, Diabetes.

[10]  Cheng Wang,et al.  Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease. , 2021, European journal of pharmacology.

[11]  Guizhi Yang,et al.  Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP‐Activated Protein Kinase Signaling Pathway , 2021, Hepatology.

[12]  Min Hu,et al.  Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats , 2021, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  Cai-fei Ding,et al.  Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway , 2020, Mediators of inflammation.

[14]  Weihong Li,et al.  Icariin and its metabolites regulate lipid metabolism: From effects to molecular mechanisms. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  Xinran Li,et al.  Icariin ameliorates endothelial dysfunction in type 1 diabetic rats by suppressing ER stress via the PPARα/Sirt1/AMPKα pathway , 2020, Journal of cellular physiology.

[16]  G. Frühbeck,et al.  Liver CPT1A gene therapy reduces diet‐induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Bangcai Wang,et al.  Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway. , 2020, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[18]  B. Wiszniewska,et al.  Sex Hormone-Dependent Physiology and Diseases of Liver , 2020, International journal of environmental research and public health.

[19]  Min Zhang,et al.  Osteocalcin prevents insulin resistance, hepatic inflammation, and activates autophagy associated with high-fat diet–induced fatty liver hemorrhagic syndrome in aged laying hens , 2020, Poultry science.

[20]  Jiaqi Liu,et al.  Icariin Protects Hippocampal Neurons From Endoplasmic Reticulum Stress and NF-κB Mediated Apoptosis in Fetal Rat Hippocampal Neurons and Asthma Rats , 2020, Frontiers in Pharmacology.

[21]  Yu-Shan Gao,et al.  Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease , 2019, World journal of gastroenterology.

[22]  Shu-Ju Wu,et al.  Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet , 2019, Cells.

[23]  Y. Tan,et al.  The Flavanone, Naringenin, Modifies Antioxidant and Steroidogenic Enzyme Activity in a Rat Model of Letrozole-Induced Polycystic Ovary Syndrome , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[24]  A. Rigby,et al.  A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome , 2019, Nutrients.

[25]  Wen‐bin Liu,et al.  The mechanism of action of a fat regulator: Glycyrrhetinic acid (GA) stimulating fatty acid transmembrane and intracellular transport in blunt snout bream (Megalobrama amblycephala). , 2018, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[26]  Andrew R. Hall,et al.  CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. , 2018, Journal of hepatology.

[27]  J. Lykkesfeldt,et al.  Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease , 2018, Cellular and Molecular Life Sciences.

[28]  C. Glass,et al.  Analysis of Genetically Diverse Macrophages Reveals Local and Domain-wide Mechanisms that Control Transcription Factor Binding and Function , 2018, Cell.

[29]  Jianwei Wang,et al.  Response of genes involved in lipid metabolism in rat epididymal white adipose tissue to different fasting conditions after long-term fructose consumption. , 2017, Biochemical and biophysical research communications.

[30]  A. Saghatelian,et al.  SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism. , 2017, Cell metabolism.

[31]  H. Ho,et al.  Hepatic manifestations of women with polycystic ovary syndrome. , 2016, Best practice & research. Clinical obstetrics & gynaecology.

[32]  M. Cree‐Green,et al.  Hepatic Steatosis is Common in Adolescents with Obesity and PCOS and Relates to De Novo Lipogenesis but not Insulin Resistance , 2016, Obesity.

[33]  Enbo Cai,et al.  Optimization of Ultrasonic Extraction of Phenolic Compounds from Epimedium brevicornum Maxim Using Response Surface Methodology and Evaluation of Its Antioxidant Activities In Vitro , 2014, Journal of analytical methods in chemistry.

[34]  Z. Varghese,et al.  Rapamycin-mediated CD36 translational suppression contributes to alleviation of hepatic steatosis. , 2014, Biochemical and biophysical research communications.

[35]  D. Mashek.  Hepatic fatty acid trafficking: multiple forks in the road. , 2013, Advances in nutrition.

[36]  S. Koo,et al.  Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis , 2013, Clinical and molecular hepatology.

[37]  Y. Yılmaz.  Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions? , 2012, Alimentary pharmacology & therapeutics.

[38]  J. González‐Gallego,et al.  Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C , 2011, Gut.

[39]  J. Miquel,et al.  Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. , 2007, Journal of hepatology.

[40]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[41]  Jan Weber,et al.  Pretranslational upregulation of microsomal CYP4A in rat liver by intake of a high-sucrose, lipid-devoid diet containing orotic acid. , 2005, Biochemical pharmacology.

[42]  T. Pineau,et al.  Peroxisome Proliferator-activated Receptor α Controls the Hepatic CYP4A Induction Adaptive Response to Starvation and Diabetes* , 1998, The Journal of Biological Chemistry.